Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes
Laura Fachal(University of Cambridge), Ian W. Brock(University of Sheffield), Michael Lush(University of Cambridge), Hiltrud Brauch(German Cancer Research Center), Jonathan P. Tyrer(University of Cambridge), Natalia Bogdanova(Medizinische Hochschule Hannover), Banu Arun(The University of Texas Health Science Center at Houston), Amie Blanco(University of California, San Francisco), Xia Jiang(Xuzhou Medical College), Mahdi Moradi Marjaneh(NIHR Imperial Biomedical Research Centre), William J. Blot(Shanghai Cancer Institute), Joe Dennis(University of Cambridge), Bernd Auber(Medizinische Hochschule Hannover), Karen A. Pooley(University of Cambridge), Jacopo Azzollini(Fondazione IRCCS Istituto Nazionale dei Tumori), Hugues Aschard(Harvard University), Daniel Barrowdale(University of Cambridge), Jamie Allen(University of Cambridge), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Aðalgeir Arason(University of Iceland), Irene L. Andrulis(University of Toronto), Katarzyna Białkowska(International Hereditary Cancer Center), Javier Benı́tez(Spanish National Cancer Research Centre), Daniel R. Barnes(University of Cambridge), Constance Turman(Harvard University), Paul L. Auer(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Carl Blomqvist(University of Helsinki), Rósa B. Barkardóttir(University of Iceland), Maya Ghoussaini(Regeneron (United States)), Ignacio Briceño(Universidad de La Sabana), Siddhartha Kar(University of Cambridge), Stig E. Bojesen(University of Copenhagen), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Bernardo Bonanni(European Institute of Oncology), Judith Balmañà(Vall d'Hebron Hospital Universitari), Audrey Lemaçon(University of Cambridge), Kristan J. Aronson(Queen's University), Simona Agata(Roswell Park Comprehensive Cancer Center), Alicia Beeghly‐Fadiel(University of Helsinki), Natalia Antonenkova(N.N. Alexandrov National Cancer Centre), Kristiina Aittomäki(University of Helsinki), Åke Borg(Lund University), M. Rosario Alonso(Spanish National Cancer Research Centre), Penny Soucy(University of Cambridge), Manjeet K. Bolla(University of Cambridge), Kristin Bosse(University of Tübingen), Marina Bermisheva(Russian Academy of Sciences), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Volker Arndt(German Cancer Research Center)
Cited by 13
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k